Pediatric Drug Application

February 18, 2025 updated by: Şerife TUTAR GÜVEN, Suleyman Demirel University

The Effects of Three Different Methods (metaverse, Jigsaw, Classical) on Students' Self-efficacy Levels in Pediatric Drug Administration

The aim of this study was to evaluate the effectiveness of jigsaw, metaverse and classical learning models in developing self-efficacy in medication administration of students taking pediatric nursing courses.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Purpose of the Study The purpose of this study is to evaluate the effects of three different learning methods (classical, metaverse, jigsaw) used in pediatric drug application skills training on students' drug application self-efficacy levels in children.

Research Hypotheses H0: There is no difference between the drug application self-efficacy levels of students in groups.

H1: There is a difference between the drug application self-efficacy levels of students in groups.

Research Form This study is a pre-test post-test randomized quasi-experimental study. In addition, when the study is completed, a qualitative interview will be conducted with 10 volunteer students in each group regarding the positive and negative aspects of the classical, jigsaw and metaverse techniques.

Place and Time of the Study The study will be conducted with students taking the Child Health and Diseases Nursing Course of the Nursing Department of the Faculty of Health Sciences at Süleyman Demirel University between April and June 2023.

The Universe and Sample of the Study The universe of the study consists of 180 students taking the Nursing Department Child Health and Diseases Nursing Course. The 90 students determined as a result of the power analysis will be formed.

Power Analysis: The power analysis of the study was performed with the GPower 3.1.9.2. (Universitaet Kiel, Germany) program. Since the study design was prepared as three independent groups and two repeated measures, "F test" was selected as the test family and "ANOVA: Repeated measures, within-between interaction" was selected as the analysis. First of all, according to the main mass information given as N=180 with the single sample ratio test, the sample size was calculated as n=63 for the p=0.40 ratio value, 5% error and 95% power value. The effect size for the variance explained by the effect for repeated measures was calculated as d=0.252 for 1. The total sample size was calculated as n=66 for three independent groups and two repeated measurements under the conditions of 5% margin of error, 0.95 power value, and r=0.5 correlation between repeated measurements. However, considering the randomization and repeated study situation, it was decided to increase the sample slightly and complete it with 30 students for each group, totaling n=90.

Criteria for inclusion in the study:

  • Being a first-time student taking the Child Health and Diseases Nursing Course
  • Being a volunteer to participate in the study

Criteria for exclusion from the study:

  • Being a Health Vocational High School graduate or being included in the program with DGS (vertical transfer exam)
  • Not being a non-resident during the dates when the data of the study were collected
  • Having received education or courses on drug applications in children in previous periods
  • Being a student taking the course from below Randomization: Students who meet the criteria for inclusion in the study will be assigned to groups with the simple randomization method (classic, metaverse, jigsaw learning). Students who do not accept to participate in the research will receive the same topic from the relevant instructor in accordance with the routine of the course.

Study Type

Interventional

Enrollment (Actual)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Isparta, Turkey, 32200
        • Suleyman Demirel University, Nursing Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Taking the Child Health and Disease Nursing Course for the first time
  • Volunteering to participate in the research

Exclusion Criteria:

  • Not doing any treatment during the dates when the research data was collected
  • Not taking any training or courses on drug applications in children in previous periods
  • Not taking the course from the bottom

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group 1
Intervention
Other: Jigsaw
In this learning method, students will be divided into main and expert groups. Then, an expert from each group will come and the student will be provided with expertise in the subject given to him/her by the instructor. After the student has specialized, he/she will return to his/her own group and will provide training to his/her friends on the subject he/she has specialized in under the supervision of the instructor of the course. During the student's specialization process on the subject given, the necessary literature support and controls will be provided by the instructor of the course.
Experimental: Intervention Group 2
Intervention
Other: Metaverse
In this learning method, the topics determined on pediatric drug applications will be prepared weekly by the relevant instructor of the course and will be transferred to the metaverse and presented to the student in the form of weekly modules.
Experimental: Control Group
Other: Classical Education
In this learning method, the subjects determined by the instructor will be explained to the students in a laboratory environment by the instructor using a presentation (power point) method.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pediatric medication administration self-efficacy scale score
Time Frame: 4 month
The self-efficacy scale for medication administration in children for nursing students was developed by Bektaş et al. in 2021. The scale consists of 16 items and two sub-dimensions. The medication preparation sub-dimension for children (items for calculating and obtaining medication doses) is items 1, 2, 3, 4, 5, 6, 7, and 8; the medication administration sub-dimension (items for administering the obtained medication) is items 9, 10, 11, 12, 13, 14, 15, and 16. This scale is graded in a 5-point Likert-type scale and is listed as 1 = Definitely not sufficient, 2 = Somewhat sufficient, 3 = Partially sufficient, 4 = Sufficient, 5 = Definitely sufficient. The lowest score obtained from the scale is 16 and the highest score is 80. The scale has no cut-off point; as the score increases, the students' self-efficacy for pediatric medication administration increases. The scale has no reverse-scored items.
4 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Suleyman Demirel University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2023

Primary Completion (Actual)

June 30, 2023

Study Completion (Actual)

June 30, 2023

Study Registration Dates

First Submitted

August 6, 2024

First Submitted That Met QC Criteria

February 18, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 18, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 72867572-050.01.04-87

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

We can share all the details once our research is published.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Drugs, Investigational

Clinical Trials on Jigsaw

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe